Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Back to basics in COVID-19: Antigens and antibodies-Completing the puzzle.

Journal of cellular and molecular medicine - 1 May 2021

Neagu Monica, Calina Daniela, Docea Anca Oana, Constantin Carolina, Filippini Tommaso, Vinceti Marco, Drakoulis Nikolaos, Poulas Konstantinos, Nikolouzakis Taxiarchis Konstantinos, Spandidos Demetrios A, Tsatsakis Aristidis

Abstract excerpt

The outbreak of the coronavirus disease 2019 (COVID-19) has gathered 1 year of scientific/clinical information. This informational asset should be thoroughly and wisely used in the coming year colliding in a global task force to control this infection. Epidemiology of this infection shows that the available estimates of SARS-CoV-2 infection prevalence largely depended on the availability of molecular testing and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Antigens, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to COVID-19 Testing

Share to Immunologic Memory

Share to Mutation

Share to Pandemics

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 33734600
DOI: 10.1111/jcmm.16462
PMCID: PMC8107083

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Back to basics in COVID-19: Antigens and antibodies-Completing the puzzle.PMID 33734600Read ↗

ANTIBODY RESPONSE TO COVID-19 INFECTION- CLINICAL VARIABLES AT PLAYSemantic proximity Read ↗

Implications of SARS‐CoV‐2 Immunity in the Context of the Pathogenesis of COVID‐19, Immune Evasion of the Virus, and the Effectiveness of VaccinationSemantic proximity Read ↗

A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational scienceSemantic proximity Read ↗

Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?Semantic proximity Read ↗

Epitope-resolved serology test differentiates the clinical outcome of COVID-19 and identifies defects in antibody response in SARS-CoV-2 variantsSemantic proximity Read ↗

The SARS-COV-2 T-Cell Immunity is Directed Against the Spike, Membrane, and Nucleocapsid Protein and Associated with COVID 19 SeveritySemantic proximity Read ↗

Discovery Proteomics for COVID-19: Where We Are NowSemantic proximity Read ↗

Autoimmunity and Antibody Dependent COVID-19 Enhancement of SARS CoV-2 Vaccination: A Global Human Right to Know then Decide.Semantic proximity Read ↗

Expansion of SARS-CoV-2-specific Antibody-secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 PatientsSemantic proximity Read ↗

An Overview of the Immune Response to COVID-19 Vaccination and Strategies to Boost SARS-CoV-2 Immunity in People with Inborn Errors of ImmunitySemantic proximity Read ↗

Role of T cells in severe COVID-19 disease, protection, and long term immunitySemantic proximity Read ↗

The SARS-CoV-2 T-cell immunity is directed against the spike, membrane, and nucleocapsid protein and associated with COVID 19 severitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.